pubmed-article:16926224 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C1336219 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C1527392 | lld:lifeskim |
pubmed-article:16926224 | lifeskim:mentions | umls-concept:C0149256 | lld:lifeskim |
pubmed-article:16926224 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:16926224 | pubmed:dateCreated | 2006-10-9 | lld:pubmed |
pubmed-article:16926224 | pubmed:abstractText | To find the optimal dose of immunomodulator Z-100 in patients with stage IIIB squamous cell carcinoma of the cervix in combination with radiation therapy. | lld:pubmed |
pubmed-article:16926224 | pubmed:language | eng | lld:pubmed |
pubmed-article:16926224 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16926224 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16926224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16926224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16926224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16926224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16926224 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16926224 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16926224 | pubmed:issn | 0368-2811 | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:OgitaSachioS | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:FujiiShingoS | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:OhashiYasuoY | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:FujiwaraKeiic... | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:NiibeHideoH | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:MoritaKozoK | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:NodaKiichiroK | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:KikuchiYuzoY | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:OzakiMasamiM | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:TakegawaYoshi... | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:OkadaHirojiH | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:HoriuchiJunic... | lld:pubmed |
pubmed-article:16926224 | pubmed:author | pubmed-author:HashimotoShoz... | lld:pubmed |
pubmed-article:16926224 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16926224 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:16926224 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16926224 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16926224 | pubmed:pagination | 570-7 | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:meshHeading | pubmed-meshheading:16926224... | lld:pubmed |
pubmed-article:16926224 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16926224 | pubmed:articleTitle | Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy. | lld:pubmed |
pubmed-article:16926224 | pubmed:affiliation | Kinki University, Japan. | lld:pubmed |
pubmed-article:16926224 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16926224 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16926224 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16926224 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16926224 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |